Presentation ACC 2025 Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial Presenter: Darren K. McGuire March 29, 2025
Presentation ESC 2017 Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease Presenter: John Eikelboom August 27, 2017
Presentation Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries Presenter: R. Khatib October 26, 2015
Presentation A Randomised Controlled Trial of Platelet Activity Before and After Cessation of Clopidogrel in Patients with Stable Cardiovascular Disease Presenter: Isobel Ford November 12, 2013